APLN and chronic kidney disease: In addition, IS treatment decreased the mRNA expression of apelin and elabela dose‐dependent manner in C2C12 myotubes, indicating that reduced apelin and elabela expression in CKD was partly caused by protein‐binding uraemic toxins.